“melinta-therapeutics” Archives

in
Entry Author Date Location
Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More 06/26/20 National
La Jolla Pharma Steps In With Better Offer, Wins Tetraphase Bidding War 06/24/20 San Diego
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Melinta Expands Antibiotics Lineup With $39M Tetraphase Acquisition 06/09/20 New York
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More 04/24/20 National
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More 03/06/20 National
Melinta’s Chapter 11 Auction Draws No Bids, Deerfield to Get Assets 03/04/20 New York
Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution’s IPO & More 02/14/20 National
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More 01/03/20 National
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections 10/22/18 San Diego
Bio Roundup: Migraine Data, Cancer Drug Combos, Azar Hearing & More 12/01/17 National
Medicines Co. Sells Infectious Disease Drugs, Focusing on PCSK9 11/29/17 New York
Bio Roundup: $1B Deals, Data Bumps, Acorda’s Lumps, Generic OKs & More 08/11/17 National
Antibiotics Firms Cempra, Melinta Therapeutics Agree to Merger 08/09/17 Raleigh Durham
Bio Roundup: Senate Trumpcare, FDA On Cancer, Alzheimer Review & More 06/23/17 National
Melinta Therapeutics Lands $67,000,000 New Financing 06/10/15 Boston
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More 02/14/14 Boston
Melinta Therapeutics Obtains $70,000,000 Series C Round 02/10/14 Boston
Page 1 of 1